111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer

NCT01445054 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

13

Enrollment

NIH

Sponsor class

Conditions

Breast Cancer
Prostate Cancer
Lung Cancer
Colon Cancer

Interventions

DRUG: 111Indium CHX-A

Sponsor

National Cancer Institute (NCI)